Impact of Remdesivir on inflammatory and prognostic markers of COVID-19: Findings of an event-monitoring study

Impact of Remdesivir on inflammatory and prognostic markers of COVID-19: Findings of an event-monitoring study

Introduction: Remdesivir is currently approved for treating hospitalised patients with COVID-19. However, it is a priority to monitor its safety and effectiveness in various clinical settings. This study was undertaken to assess the impact of remdesivir on inflammatory and prognostic markers of COVI...

Full description

Saved in:

Bibliographic Details
Main Authors:	Shruti Singh, Nishi Sinha, Pallavi Lohani, Neha Agarwal, Pratibha Singh, CM Singh
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2023-12-01
Series:	Journal of Family Medicine and Primary Care
Subjects:	adverse drug reaction profile inflammatory biomarkers prognostic markers remdesivir survival analysis
Online Access:	https://journals.lww.com/10.4103/jfmpc.jfmpc_334_23
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Remdesivir-induced severe hypoglycemia in an elderly man without diabetes: a case report
by: Yasunori Nagano, et al.
Published: (2025-01-01)

Ecofriendly spectrophotometric methods for simultaneous determination of remdesivir and moxifloxacin hydrochloride as co administered drugs in corona virus treatment
by: Eman A. Madbouly, et al.
Published: (2025-01-01)

Effects of Remdesivir (GS-5734) on Anti-Müllerian Hormone Level and Ovarian Tissues Morphology in Experimental Female Rats
by: Zainab Waleed Aziz, et al.
Published: (2024-09-01)

Clinical outcomes of early remdesivir administration in hospitalized patients at high risk for severe COVID-19 during the Omicron wave
by: Yeon Ju La, et al.
Published: (2025-02-01)

Assessment of Favipiravir and Remdesivir in Combination for SARS-CoV-2 Infection in Syrian Golden Hamsters
by: Megan Neary, et al.
Published: (2024-11-01)

A Randomized, Blinded, Vehicle-Controlled Dose-Ranging Study to Evaluate and Characterize Remdesivir Efficacy Against Ebola Virus in Rhesus Macaques
by: Elizabeth E. Zumbrun, et al.
Published: (2024-12-01)

Investigating the effects of remdesivir on corrected QT interval in patients with severe COVID-19 disease: a historical cohort study
by: Homina Saffar, et al.
Published: (2024-12-01)

Single-cell RNA sequencing analysis reveals potential key prognostic markers in hepatocellular carcinoma
by: Heteng Cui, et al.
Published: (2024-12-01)

Perioperative infections as a prognostic risk factor in hepatocellular carcinoma and cholangiocellular carcinoma: a comparative analysis
by: Markus S. Jördens, et al.
Published: (2025-01-01)

Early combination of sotrovimab with nirmatrelvir/ritonavir or remdesivir is associated with low rate of persisting SARS CoV-2 infection in immunocompromised outpatients with mild-to-moderate COVID-19: a prospective single-centre study
by: I. Gentile, et al.
Published: (2025-12-01)

Assessing in vitro stability of remdesivir (GS-5734) and conversion to GS-441524 in feline plasma and whole blood
by: Sally J. Coggins, et al.
Published: (2024-12-01)

Repetitive stability study of remdesivir/cyclodextrin complex on the international space station
by: György Dormán, et al.
Published: (2025-02-01)

Biocompatible, controlled-release remdesivir-loaded liposomes tackling the telomerase activity of Non-Small cell lung cancer cells: Preparation, characterization, in vitro biological evaluation, and molecular docking analysis
by: Hadeer M. Soudan, et al.
Published: (2024-01-01)

Remdesivir and mortality reduction in COVID-19 patients: a systematized subgroup analysis of clinical trials
by: Emilio Jesús Alegre-del Rey, et al.
Published: (2021-01-01)

Real-world evidence of remdesivir in formerly hospitalized COVID-19 patients: patient-reported and functional outcomes
by: Dorottya Fésü, et al.
Published: (2025-01-01)

High expression of MRPL52 can be used as a prognostic marker of hepatocellular carcinoma and is related to immune infiltration
by: Nan HUANG, et al.
Published: (2021-12-01)

Prognostic value of pro-inflammatory markers at the preoperative stage in Algerian women with breast cancer
by: Zergoun Ahmed Amine, et al.
Published: (2024-06-01)

Prognostic Indicators for Precision Treatment of Non-Small Cell Lung Carcinoma
by: Damayanti Das Ghosh, et al.
Published: (2024-10-01)

Significance of Biogenetic Markers in Giant Cell Tumor Differentiation and Prognosis: A Narrative Review
by: Muhammad Taqi, et al.
Published: (2024-12-01)

Novel Inflammatory Prognostic Markers in Lung Cancer Patients Treated with Definitive Chemoradiotherapy
by: Hakan Harputluoglu, et al.
Published: (2022-12-01)

Prognostic markers in oesophageal and gastric cancer review. Are they ready for clinical practice?
by: V. Kunene, et al.
Published: (2024-12-01)

Determinants of Survival in Cancer Rectum: Our Experience at a Tertiary Care Center
by: Rashmi Singh, et al.
Published: (2024-12-01)

Prognostic role of prognostic nutritional index in patients with bladder cancer: a systematic review and meta-analysis
by: Jing Sun, et al.
Published: (2025-01-01)

Prognostic value of the pretreatment Naples prognostic score in patients with colorectal cancer: a systematic review and meta-analysis
by: Hui Liu, et al.
Published: (2025-01-01)

Aminotransferase-to-lymphocyte ratio as a valuable prognostic marker for patients with stage I-III colorectal cancer: a retrospective study
by: Hailun Xie, et al.
Published: (2024-11-01)

Interleukin-6 as a Pan-Cancer Prognostic Inflammatory Biomarker: A Population-Based Study and Comprehensive Bioinformatics Analysis
by: Xie H, et al.
Published: (2025-01-01)

Diagnostic and Prognostic Significance of Exosomes and Their Components in Patients With Cancers
by: Zinnat Ara Moni, et al.
Published: (2025-01-01)

Niemann–Pick C1-like 1 as a Prognostic Marker in Renal Cell Carcinoma: A Retrospective Cohort Study
by: Ryuk Jun Kwon, et al.
Published: (2024-11-01)

Comprehensive analysis of the expression and prognostic value of ARMCs in pancreatic adenocarcinoma
by: Guanxiang Zhuo, et al.
Published: (2025-01-01)

Role of biomarkers in prognostication of moderate and severe COVID-19 cases
by: Santasmita Pal, et al.
Published: (2023-12-01)

Prognostic significance of preoperative prognostic nutritional index in hepatocellular carcinoma after curative hepatectomy: a meta-analysis and systemic review
by: Haiyan Zhang, et al.
Published: (2024-12-01)

Prognostic Value of Inflammatory and Nutritional Indicators in Non-Metastatic Soft Tissue Sarcomas
by: Yan Y, et al.
Published: (2025-02-01)

Association of the Naples Prognostic Score with Long-Term Adverse Events in Chronic Limb-Threatening Ischemia After Below-the-Knee Endovascular Revascularization
by: Emir Dervis, et al.
Published: (2024-11-01)

Predictive role of the prognostic nutritional index for long-term prognosis among patients undergoing pancreatoduodenectomy: a meta-analysis
by: Ying Liu, et al.
Published: (2025-01-01)

Prognostic value of the derived inflammatory marker SIRI in postmenopausal women with coronary artery disease
by: Pengli Yang, et al.
Published: (2024-12-01)

TOM40 as a prognostic oncogene for oral squamous cell carcinoma prognosis
by: Lifei Deng, et al.
Published: (2025-01-01)

Prognostic nomograms for young breast cancer: A retrospective study based on the SEER and METABRIC databases
by: Yongxin Li, et al.
Published: (2024-12-01)

Prognostic Models of Primary Sclerosing Cholangitis
by: A. I. Dolgushina, et al.
Published: (2023-02-01)

Thyroid cancer survival and prognostic factors in Yantai, China (2012–2022): a population-based study
by: Haiyun Liu, et al.
Published: (2024-12-01)

Comparing the associations between host and tumor factors with survival outcomes with anti‐PD‐1 immunotherapy in metastatic melanoma
by: Kim Koczka, et al.
Published: (2023-02-01)